ClinicalTrials.Veeva

Menu

RapidShock Post-Approval Study

ZOLL Medical logo

ZOLL Medical

Status

Completed

Conditions

Cardiac Arrest

Treatments

Device: RapidShock

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Compare the performance of the Reconfirmation Analysis Mode algorithm to the performance goals recommended by the American Heart Association.

Enrollment

2,756 patients

Sex

All

Ages

8+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 8 years of age or older and weight ≥ 55 lbs (25 kgs)
  • Out-of-hospital cardiac arrest (OOHCA)
  • Non-traumatic cardiac arrest

Exclusion criteria

  • Weight less than 55 lbs (25 kgs)
  • Do not attempt resuscitation (DNAR) orders

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

2,756 participants in 1 patient group

RapidShock
Other group
Description:
Patients receiving xseries device with rapid shock enabled
Treatment:
Device: RapidShock

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems